Global Proteomics Market 2023-2027
Global Proteomics Market 2023-2027 The proteomics market is forecasted to grow by USD 21,749.32 mn during 2022-2027, accelerating at a CAGR of 13.05% during the forecast period. The report on the ... もっと見る
SummaryGlobal Proteomics Market 2023-2027The proteomics market is forecasted to grow by USD 21,749.32 mn during 2022-2027, accelerating at a CAGR of 13.05% during the forecast period. The report on the proteomics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing advances in proteomics research, the emergence of precision proteomics, and increasing automation in proteomics. Technavio's proteomics market is segmented as below: By Product • Reagents • Instruments • Services By End-user • Clinical diagnostics • Drug discovery • Others By Geographical Landscape • North America • Europe • Asia • Rest of World (ROW) This study identifies the growing focus on monitoring PTMs as one of the prime reasons driving the proteomics market growth during the next few years. Also, the emergence of label-free quantification techniques and increasing demand for personalized medicine will lead to sizable demand in the market. The report on the proteomics market covers the following areas: • Proteomics market sizing • Proteomics market forecast • Proteomics market industry analysis The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading proteomics market vendors that include Agilent Technologies Inc., Applied Biomics Inc., Bio Rad Laboratories Inc., Biognosys AG, Bruker Corp., CellCarta Biosciences Inc., Creative Proteomics, DiaSorin Spa, F. Hoffmann La Roche Ltd., Geno Technology Inc., HORIBA Ltd., Merck KGaA, Olink Holding AB, Perkin Elmer Inc., Promega Corp., QIAGEN NV, Thermo Fisher Scientific Inc., Waters Corp., Cell Signaling Technology Inc., and Illumina Inc.. Also, the proteomics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities. The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit - https://www.technavio.com/report/proteomics-market-industry-analysis The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth. Table of Contents• 1 Executive Summaryo 1.1 Market overview o Exhibit 01: Executive Summary - Chart on Market Overview o Exhibit 02: Executive Summary - Data Table on Market Overview o Exhibit 03: Executive Summary - Chart on Global Market Characteristics o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape o Exhibit 05: Executive Summary - Chart on Market Segmentation by Product o Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user o Exhibit 07: Executive Summary - Chart on Incremental Growth o Exhibit 08: Executive Summary - Data Table on Incremental Growth o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning • 2 Market Landscape o 2.1 Market ecosystem o Exhibit 10: Parent market o Exhibit 11: Market Characteristics • 3 Market Sizing o 3.1 Market definition o Exhibit 12: Offerings of vendors included in the market definition o 3.2 Market segment analysis o Exhibit 13: Market segments o 3.3 Market size 2022 o 3.4 Market outlook: Forecast for 2022-2027 o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million) o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million) o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%) o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%) • 4 Historic Market Size o 4.1 Global proteomics market 2017 - 2021 o Exhibit 18: Historic Market Size - Data Table on global proteomics market 2017 - 2021 ($ million) o 4.2 Product Segment Analysis 2017 - 2021 o Exhibit 19: Historic Market Size - Product Segment 2017 - 2021 ($ million) o 4.3 End-user Segment Analysis 2017 - 2021 o Exhibit 20: Historic Market Size - End-user Segment 2017 - 2021 ($ million) o 4.4 Geography Segment Analysis 2017 - 2021 o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million) o 4.5 Country Segment Analysis 2017 - 2021 o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million) • 5 Five Forces Analysis o 5.1 Five forces summary o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027 o 5.2 Bargaining power of buyers o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027 o 5.3 Bargaining power of suppliers o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027 o 5.4 Threat of new entrants o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027 o 5.5 Threat of substitutes o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027 o 5.6 Threat of rivalry o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027 o 5.7 Market condition o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027 • 6 Market Segmentation by Product o 6.1 Market segments o Exhibit 30: Chart on Product - Market share 2022-2027 (%) o Exhibit 31: Data Table on Product - Market share 2022-2027 (%) o 6.2 Comparison by Product o Exhibit 32: Chart on Comparison by Product o Exhibit 33: Data Table on Comparison by Product o 6.3 Reagents - Market size and forecast 2022-2027 o Exhibit 34: Chart on Reagents - Market size and forecast 2022-2027 ($ million) o Exhibit 35: Data Table on Reagents - Market size and forecast 2022-2027 ($ million) o Exhibit 36: Chart on Reagents - Year-over-year growth 2022-2027 (%) o Exhibit 37: Data Table on Reagents - Year-over-year growth 2022-2027 (%) o 6.4 Instruments - Market size and forecast 2022-2027 o Exhibit 38: Chart on Instruments - Market size and forecast 2022-2027 ($ million) o Exhibit 39: Data Table on Instruments - Market size and forecast 2022-2027 ($ million) o Exhibit 40: Chart on Instruments - Year-over-year growth 2022-2027 (%) o Exhibit 41: Data Table on Instruments - Year-over-year growth 2022-2027 (%) o 6.5 Services - Market size and forecast 2022-2027 o Exhibit 42: Chart on Services - Market size and forecast 2022-2027 ($ million) o Exhibit 43: Data Table on Services - Market size and forecast 2022-2027 ($ million) o Exhibit 44: Chart on Services - Year-over-year growth 2022-2027 (%) o Exhibit 45: Data Table on Services - Year-over-year growth 2022-2027 (%) o 6.6 Market opportunity by Product o Exhibit 46: Market opportunity by Product ($ million) o Exhibit 47: Data Table on Market opportunity by Product ($ million) • 7 Market Segmentation by End-user o 7.1 Market segments o Exhibit 48: Chart on End-user - Market share 2022-2027 (%) o Exhibit 49: Data Table on End-user - Market share 2022-2027 (%) o 7.2 Comparison by End-user o Exhibit 50: Chart on Comparison by End-user o Exhibit 51: Data Table on Comparison by End-user o 7.3 Clinical diagnostics - Market size and forecast 2022-2027 o Exhibit 52: Chart on Clinical diagnostics - Market size and forecast 2022-2027 ($ million) o Exhibit 53: Data Table on Clinical diagnostics - Market size and forecast 2022-2027 ($ million) o Exhibit 54: Chart on Clinical diagnostics - Year-over-year growth 2022-2027 (%) o Exhibit 55: Data Table on Clinical diagnostics - Year-over-year growth 2022-2027 (%) o 7.4 Drug discovery - Market size and forecast 2022-2027 o Exhibit 56: Chart on Drug discovery - Market size and forecast 2022-2027 ($ million) o Exhibit 57: Data Table on Drug discovery - Market size and forecast 2022-2027 ($ million) o Exhibit 58: Chart on Drug discovery - Year-over-year growth 2022-2027 (%) o Exhibit 59: Data Table on Drug discovery - Year-over-year growth 2022-2027 (%) o 7.5 Others - Market size and forecast 2022-2027 o Exhibit 60: Chart on Others - Market size and forecast 2022-2027 ($ million) o Exhibit 61: Data Table on Others - Market size and forecast 2022-2027 ($ million) o Exhibit 62: Chart on Others - Year-over-year growth 2022-2027 (%) o Exhibit 63: Data Table on Others - Year-over-year growth 2022-2027 (%) o 7.6 Market opportunity by End-user o Exhibit 64: Market opportunity by End-user ($ million) o Exhibit 65: Data Table on Market opportunity by End-user ($ million) • 8 Customer Landscape o 8.1 Customer landscape overview o Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria • 9 Geographic Landscape o 9.1 Geographic segmentation o Exhibit 67: Chart on Market share By Geographical Landscape 2022-2027 (%) o Exhibit 68: Data Table on Market share By Geographical Landscape 2022-2027 (%) o 9.2 Geographic comparison o Exhibit 69: Chart on Geographic comparison o Exhibit 70: Data Table on Geographic comparison o 9.3 North America - Market size and forecast 2022-2027 o Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ million) o Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ million) o Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%) o Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%) o 9.4 Europe - Market size and forecast 2022-2027 o Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ million) o Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million) o Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%) o Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%) o 9.5 Asia - Market size and forecast 2022-2027 o Exhibit 79: Chart on Asia - Market size and forecast 2022-2027 ($ million) o Exhibit 80: Data Table on Asia - Market size and forecast 2022-2027 ($ million) o Exhibit 81: Chart on Asia - Year-over-year growth 2022-2027 (%) o Exhibit 82: Data Table on Asia - Year-over-year growth 2022-2027 (%) o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027 o Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million) o Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million) o Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%) o Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%) o 9.7 US - Market size and forecast 2022-2027 o Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ million) o Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ million) o Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%) o Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%) o 9.8 UK - Market size and forecast 2022-2027 o Exhibit 91: Chart on UK - Market size and forecast 2022-2027 ($ million) o Exhibit 92: Data Table on UK - Market size and forecast 2022-2027 ($ million) o Exhibit 93: Chart on UK - Year-over-year growth 2022-2027 (%) o Exhibit 94: Data Table on UK - Year-over-year growth 2022-2027 (%) o 9.9 Germany - Market size and forecast 2022-2027 o Exhibit 95: Chart on Germany - Market size and forecast 2022-2027 ($ million) o Exhibit 96: Data Table on Germany - Market size and forecast 2022-2027 ($ million) o Exhibit 97: Chart on Germany - Year-over-year growth 2022-2027 (%) o Exhibit 98: Data Table on Germany - Year-over-year growth 2022-2027 (%) o 9.10 China - Market size and forecast 2022-2027 o Exhibit 99: Chart on China - Market size and forecast 2022-2027 ($ million) o Exhibit 100: Data Table on China - Market size and forecast 2022-2027 ($ million) o Exhibit 101: Chart on China - Year-over-year growth 2022-2027 (%) o Exhibit 102: Data Table on China - Year-over-year growth 2022-2027 (%) o 9.11 Japan - Market size and forecast 2022-2027 o Exhibit 103: Chart on Japan - Market size and forecast 2022-2027 ($ million) o Exhibit 104: Data Table on Japan - Market size and forecast 2022-2027 ($ million) o Exhibit 105: Chart on Japan - Year-over-year growth 2022-2027 (%) o Exhibit 106: Data Table on Japan - Year-over-year growth 2022-2027 (%) o 9.12 Market opportunity By Geographical Landscape o Exhibit 107: Market opportunity By Geographical Landscape ($ million) o Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million) • 10 Drivers, Challenges, and Trends o 10.1 Market drivers o 10.2 Market challenges o 10.3 Impact of drivers and challenges o Exhibit 109: Impact of drivers and challenges in 2022 and 2027 o 10.4 Market trends • 11 Vendor Landscape o 11.1 Overview o 11.2 Vendor landscape o Exhibit 110: Overview on Criticality of inputs and Factors of differentiation o 11.3 Landscape disruption o Exhibit 111: Overview on factors of disruption o 11.4 Industry risks o Exhibit 112: Impact of key risks on business • 12 Vendor Analysis o 12.1 Vendors covered o Exhibit 113: Vendors covered o 12.2 Market positioning of vendors o Exhibit 114: Matrix on vendor position and classification o 12.3 Agilent Technologies Inc. o Exhibit 115: Agilent Technologies Inc. - Overview o Exhibit 116: Agilent Technologies Inc. - Business segments o Exhibit 117: Agilent Technologies Inc. - Key offerings o Exhibit 118: Agilent Technologies Inc. - Segment focus o 12.4 Bio Rad Laboratories Inc. o Exhibit 119: Bio Rad Laboratories Inc. - Overview o Exhibit 120: Bio Rad Laboratories Inc. - Business segments o Exhibit 121: Bio Rad Laboratories Inc. - Key news o Exhibit 122: Bio Rad Laboratories Inc. - Key offerings o Exhibit 123: Bio Rad Laboratories Inc. - Segment focus o 12.5 Bruker Corp. o Exhibit 124: Bruker Corp. - Overview o Exhibit 125: Bruker Corp. - Business segments o Exhibit 126: Bruker Corp. - Key news o Exhibit 127: Bruker Corp. - Key offerings o Exhibit 128: Bruker Corp. - Segment focus o 12.6 CellCarta Biosciences Inc. o Exhibit 129: CellCarta Biosciences Inc. - Overview o Exhibit 130: CellCarta Biosciences Inc. - Product / Service o Exhibit 131: CellCarta Biosciences Inc. - Key offerings o 12.7 Creative Proteomics o Exhibit 132: Creative Proteomics - Overview o Exhibit 133: Creative Proteomics - Product / Service o Exhibit 134: Creative Proteomics - Key offerings o 12.8 DiaSorin Spa o Exhibit 135: DiaSorin Spa - Overview o Exhibit 136: DiaSorin Spa - Business segments o Exhibit 137: DiaSorin Spa - Key offerings o Exhibit 138: DiaSorin Spa - Segment focus o 12.9 F. Hoffmann La Roche Ltd. o Exhibit 139: F. Hoffmann La Roche Ltd. - Overview o Exhibit 140: F. Hoffmann La Roche Ltd. - Business segments o Exhibit 141: F. Hoffmann La Roche Ltd. - Key news o Exhibit 142: F. Hoffmann La Roche Ltd. - Key offerings o Exhibit 143: F. Hoffmann La Roche Ltd. - Segment focus o 12.10 HORIBA Ltd. o Exhibit 144: HORIBA Ltd. - Overview o Exhibit 145: HORIBA Ltd. - Business segments o Exhibit 146: HORIBA Ltd. - Key news o Exhibit 147: HORIBA Ltd. - Key offerings o Exhibit 148: HORIBA Ltd. - Segment focus o 12.11 Illumina Inc. o Exhibit 149: Illumina Inc. - Overview o Exhibit 150: Illumina Inc. - Business segments o Exhibit 151: Illumina Inc. - Key news o Exhibit 152: Illumina Inc. - Key offerings o Exhibit 153: Illumina Inc. - Segment focus o 12.12 Merck KGaA o Exhibit 154: Merck KGaA - Overview o Exhibit 155: Merck KGaA - Business segments o Exhibit 156: Merck KGaA - Key news o Exhibit 157: Merck KGaA - Key offerings o Exhibit 158: Merck KGaA - Segment focus o 12.13 Perkin Elmer Inc. o Exhibit 159: Perkin Elmer Inc. - Overview o Exhibit 160: Perkin Elmer Inc. - Business segments o Exhibit 161: Perkin Elmer Inc. - Key news o Exhibit 162: Perkin Elmer Inc. - Key offerings o Exhibit 163: Perkin Elmer Inc. - Segment focus o 12.14 Promega Corp. o Exhibit 164: Promega Corp. - Overview o Exhibit 165: Promega Corp. - Product / Service o Exhibit 166: Promega Corp. - Key offerings o 12.15 QIAGEN NV o Exhibit 167: QIAGEN NV - Overview o Exhibit 168: QIAGEN NV - Product / Service o Exhibit 169: QIAGEN NV - Key news o Exhibit 170: QIAGEN NV - Key offerings o 12.16 Thermo Fisher Scientific Inc. o Exhibit 171: Thermo Fisher Scientific Inc. - Overview o Exhibit 172: Thermo Fisher Scientific Inc. - Business segments o Exhibit 173: Thermo Fisher Scientific Inc. - Key news o Exhibit 174: Thermo Fisher Scientific Inc. - Key offerings o Exhibit 175: Thermo Fisher Scientific Inc. - Segment focus o 12.17 Waters Corp. o Exhibit 176: Waters Corp. - Overview o Exhibit 177: Waters Corp. - Business segments o Exhibit 178: Waters Corp. - Key news o Exhibit 179: Waters Corp. - Key offerings o Exhibit 180: Waters Corp. - Segment focus • 13 Appendix o 13.1 Scope of the report o 13.2 Inclusions and exclusions checklist o Exhibit 181: Inclusions checklist o Exhibit 182: Exclusions checklist o 13.3 Currency conversion rates for US$ o Exhibit 183: Currency conversion rates for US$ o 13.4 Research methodology o Exhibit 184: Research methodology o Exhibit 185: Validation techniques employed for market sizing o Exhibit 186: Information sources o 13.5 List of abbreviations o Exhibit 187: List of abbreviations Exhibits: Exhibits1: Executive Summary - Chart on Market Overview Exhibits2: Executive Summary - Data Table on Market Overview Exhibits3: Executive Summary - Chart on Global Market Characteristics Exhibits4: Executive Summary - Chart on Market By Geographical Landscape Exhibits5: Executive Summary - Chart on Market Segmentation by Product Exhibits6: Executive Summary - Chart on Market Segmentation by End-user Exhibits7: Executive Summary - Chart on Incremental Growth Exhibits8: Executive Summary - Data Table on Incremental Growth Exhibits9: Executive Summary - Chart on Vendor Market Positioning Exhibits10: Parent market Exhibits11: Market Characteristics Exhibits12: Offerings of vendors included in the market definition Exhibits13: Market segments Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million) Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million) Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%) Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%) Exhibits18: Historic Market Size - Data Table on global proteomics market 2017 - 2021 ($ million) Exhibits19: Historic Market Size - Product Segment 2017 - 2021 ($ million) Exhibits20: Historic Market Size - End-user Segment 2017 - 2021 ($ million) Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million) Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million) Exhibits23: Five forces analysis - Comparison between 2022 and 2027 Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027 Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027 Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027 Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027 Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027 Exhibits29: Chart on Market condition - Five forces 2022 and 2027 Exhibits30: Chart on Product - Market share 2022-2027 (%) Exhibits31: Data Table on Product - Market share 2022-2027 (%) Exhibits32: Chart on Comparison by Product Exhibits33: Data Table on Comparison by Product Exhibits34: Chart on Reagents - Market size and forecast 2022-2027 ($ million) Exhibits35: Data Table on Reagents - Market size and forecast 2022-2027 ($ million) Exhibits36: Chart on Reagents - Year-over-year growth 2022-2027 (%) Exhibits37: Data Table on Reagents - Year-over-year growth 2022-2027 (%) Exhibits38: Chart on Instruments - Market size and forecast 2022-2027 ($ million) Exhibits39: Data Table on Instruments - Market size and forecast 2022-2027 ($ million) Exhibits40: Chart on Instruments - Year-over-year growth 2022-2027 (%) Exhibits41: Data Table on Instruments - Year-over-year growth 2022-2027 (%) Exhibits42: Chart on Services - Market size and forecast 2022-2027 ($ million) Exhibits43: Data Table on Services - Market size and forecast 2022-2027 ($ million) Exhibits44: Chart on Services - Year-over-year growth 2022-2027 (%) Exhibits45: Data Table on Services - Year-over-year growth 2022-2027 (%) Exhibits46: Market opportunity by Product ($ million) Exhibits47: Data Table on Market opportunity by Product ($ million) Exhibits48: Chart on End-user - Market share 2022-2027 (%) Exhibits49: Data Table on End-user - Market share 2022-2027 (%) Exhibits50: Chart on Comparison by End-user Exhibits51: Data Table on Comparison by End-user Exhibits52: Chart on Clinical diagnostics - Market size and forecast 2022-2027 ($ million) Exhibits53: Data Table on Clinical diagnostics - Market size and forecast 2022-2027 ($ million) Exhibits54: Chart on Clinical diagnostics - Year-over-year growth 2022-2027 (%) Exhibits55: Data Table on Clinical diagnostics - Year-over-year growth 2022-2027 (%) Exhibits56: Chart on Drug discovery - Market size and forecast 2022-2027 ($ million) Exhibits57: Data Table on Drug discovery - Market size and forecast 2022-2027 ($ million) Exhibits58: Chart on Drug discovery - Year-over-year growth 2022-2027 (%) Exhibits59: Data Table on Drug discovery - Year-over-year growth 2022-2027 (%) Exhibits60: Chart on Others - Market size and forecast 2022-2027 ($ million) Exhibits61: Data Table on Others - Market size and forecast 2022-2027 ($ million) Exhibits62: Chart on Others - Year-over-year growth 2022-2027 (%) Exhibits63: Data Table on Others - Year-over-year growth 2022-2027 (%) Exhibits64: Market opportunity by End-user ($ million) Exhibits65: Data Table on Market opportunity by End-user ($ million) Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria Exhibits67: Chart on Market share By Geographical Landscape 2022-2027 (%) Exhibits68: Data Table on Market share By Geographical Landscape 2022-2027 (%) Exhibits69: Chart on Geographic comparison Exhibits70: Data Table on Geographic comparison Exhibits71: Chart on North America - Market size and forecast 2022-2027 ($ million) Exhibits72: Data Table on North America - Market size and forecast 2022-2027 ($ million) Exhibits73: Chart on North America - Year-over-year growth 2022-2027 (%) Exhibits74: Data Table on North America - Year-over-year growth 2022-2027 (%) Exhibits75: Chart on Europe - Market size and forecast 2022-2027 ($ million) Exhibits76: Data Table on Europe - Market size and forecast 2022-2027 ($ million) Exhibits77: Chart on Europe - Year-over-year growth 2022-2027 (%) Exhibits78: Data Table on Europe - Year-over-year growth 2022-2027 (%) Exhibits79: Chart on Asia - Market size and forecast 2022-2027 ($ million) Exhibits80: Data Table on Asia - Market size and forecast 2022-2027 ($ million) Exhibits81: Chart on Asia - Year-over-year growth 2022-2027 (%) Exhibits82: Data Table on Asia - Year-over-year growth 2022-2027 (%) Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million) Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million) Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%) Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%) Exhibits87: Chart on US - Market size and forecast 2022-2027 ($ million) Exhibits88: Data Table on US - Market size and forecast 2022-2027 ($ million) Exhibits89: Chart on US - Year-over-year growth 2022-2027 (%) Exhibits90: Data Table on US - Year-over-year growth 2022-2027 (%) Exhibits91: Chart on UK - Market size and forecast 2022-2027 ($ million) Exhibits92: Data Table on UK - Market size and forecast 2022-2027 ($ million) Exhibits93: Chart on UK - Year-over-year growth 2022-2027 (%) Exhibits94: Data Table on UK - Year-over-year growth 2022-2027 (%) Exhibits95: Chart on Germany - Market size and forecast 2022-2027 ($ million) Exhibits96: Data Table on Germany - Market size and forecast 2022-2027 ($ million) Exhibits97: Chart on Germany - Year-over-year growth 2022-2027 (%) Exhibits98: Data Table on Germany - Year-over-year growth 2022-2027 (%) Exhibits99: Chart on China - Market size and forecast 2022-2027 ($ million) Exhibits100: Data Table on China - Market size and forecast 2022-2027 ($ million) Exhibits101: Chart on China - Year-over-year growth 2022-2027 (%) Exhibits102: Data Table on China - Year-over-year growth 2022-2027 (%) Exhibits103: Chart on Japan - Market size and forecast 2022-2027 ($ million) Exhibits104: Data Table on Japan - Market size and forecast 2022-2027 ($ million) Exhibits105: Chart on Japan - Year-over-year growth 2022-2027 (%) Exhibits106: Data Table on Japan - Year-over-year growth 2022-2027 (%) Exhibits107: Market opportunity By Geographical Landscape ($ million) Exhibits108: Data Tables on Market opportunity By Geographical Landscape ($ million) Exhibits109: Impact of drivers and challenges in 2022 and 2027 Exhibits110: Overview on Criticality of inputs and Factors of differentiation Exhibits111: Overview on factors of disruption Exhibits112: Impact of key risks on business Exhibits113: Vendors covered Exhibits114: Matrix on vendor position and classification Exhibits115: Agilent Technologies Inc. - Overview Exhibits116: Agilent Technologies Inc. - Business segments Exhibits117: Agilent Technologies Inc. - Key offerings Exhibits118: Agilent Technologies Inc. - Segment focus Exhibits119: Bio Rad Laboratories Inc. - Overview Exhibits120: Bio Rad Laboratories Inc. - Business segments Exhibits121: Bio Rad Laboratories Inc. - Key news Exhibits122: Bio Rad Laboratories Inc. - Key offerings Exhibits123: Bio Rad Laboratories Inc. - Segment focus Exhibits124: Bruker Corp. - Overview Exhibits125: Bruker Corp. - Business segments Exhibits126: Bruker Corp. - Key news Exhibits127: Bruker Corp. - Key offerings Exhibits128: Bruker Corp. - Segment focus Exhibits129: CellCarta Biosciences Inc. - Overview Exhibits130: CellCarta Biosciences Inc. - Product / Service Exhibits131: CellCarta Biosciences Inc. - Key offerings Exhibits132: Creative Proteomics - Overview Exhibits133: Creative Proteomics - Product / Service Exhibits134: Creative Proteomics - Key offerings Exhibits135: DiaSorin Spa - Overview Exhibits136: DiaSorin Spa - Business segments Exhibits137: DiaSorin Spa - Key offerings Exhibits138: DiaSorin Spa - Segment focus Exhibits139: F. Hoffmann La Roche Ltd. - Overview Exhibits140: F. Hoffmann La Roche Ltd. - Business segments Exhibits141: F. Hoffmann La Roche Ltd. - Key news Exhibits142: F. Hoffmann La Roche Ltd. - Key offerings Exhibits143: F. Hoffmann La Roche Ltd. - Segment focus Exhibits144: HORIBA Ltd. - Overview Exhibits145: HORIBA Ltd. - Business segments Exhibits146: HORIBA Ltd. - Key news Exhibits147: HORIBA Ltd. - Key offerings Exhibits148: HORIBA Ltd. - Segment focus Exhibits149: Illumina Inc. - Overview Exhibits150: Illumina Inc. - Business segments Exhibits151: Illumina Inc. - Key news Exhibits152: Illumina Inc. - Key offerings Exhibits153: Illumina Inc. - Segment focus Exhibits154: Merck KGaA - Overview Exhibits155: Merck KGaA - Business segments Exhibits156: Merck KGaA - Key news Exhibits157: Merck KGaA - Key offerings Exhibits158: Merck KGaA - Segment focus Exhibits159: Perkin Elmer Inc. - Overview Exhibits160: Perkin Elmer Inc. - Business segments Exhibits161: Perkin Elmer Inc. - Key news Exhibits162: Perkin Elmer Inc. - Key offerings Exhibits163: Perkin Elmer Inc. - Segment focus Exhibits164: Promega Corp. - Overview Exhibits165: Promega Corp. - Product / Service Exhibits166: Promega Corp. - Key offerings Exhibits167: QIAGEN NV - Overview Exhibits168: QIAGEN NV - Product / Service Exhibits169: QIAGEN NV - Key news Exhibits170: QIAGEN NV - Key offerings Exhibits171: Thermo Fisher Scientific Inc. - Overview Exhibits172: Thermo Fisher Scientific Inc. - Business segments Exhibits173: Thermo Fisher Scientific Inc. - Key news Exhibits174: Thermo Fisher Scientific Inc. - Key offerings Exhibits175: Thermo Fisher Scientific Inc. - Segment focus Exhibits176: Waters Corp. - Overview Exhibits177: Waters Corp. - Business segments Exhibits178: Waters Corp. - Key news Exhibits179: Waters Corp. - Key offerings Exhibits180: Waters Corp. - Segment focus Exhibits181: Inclusions checklist Exhibits182: Exclusions checklist Exhibits183: Currency conversion rates for US$ Exhibits184: Research methodology Exhibits185: Validation techniques employed for market sizing Exhibits186: Information sources Exhibits187: List of abbreviations
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療/ヘルスケア)の最新刊レポート
TechNavio社のHealth Care分野での最新刊レポート本レポートと同じKEY WORD(proteomics)の最新刊レポート
よくあるご質問TechNavio社はどのような調査会社ですか?テクナビオ(TechNavio)は英国ロンドンに本社をおく幅広い市場を調査対象とする調査会社インフィニティリサーチ社(Infiniti Research)の調査レポート出版部門です。データリソースはT... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|